DEANNA M SIEMER
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- JACKSON, MO
- NPI
- 1851368153
- Received
- $13,199 in 829 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 96 | $1,586 |
| 2024 | General payment | 134 | $2,243 |
| 2023 | General payment | 144 | $2,402 |
| 2022 | General payment | 120 | $2,215 |
| 2021 | General payment | 123 | $1,924 |
| 2020 | General payment | 112 | $1,586 |
| 2019 | General payment | 100 | $1,239 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 825 | $13,017 |
| Education | 4 | $181 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-16 | Dexcom, Inc. | $14 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-12-15 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-12-10 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-03 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-11-18 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-14 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-11-10 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-11-03 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-03 | Dexcom, Inc. | $16 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-10-24 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-21 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-20 | Amgen Inc. | $12 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-17 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-15 | Bayer Healthcare Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-06 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | SHINGRIX Biological, VACCINES | 2025 | |
| 2025-10-01 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-30 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-30 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-09-29 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-09-20 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-18 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-09-15 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-10 | Dexcom, Inc. | $20 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-09-06 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-09-05 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-09-03 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-27 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-27 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-11 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-08-11 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-07 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-08-06 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-31 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-07-17 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-14 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-09 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-08 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-02 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-06-25 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-25 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-06-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-13 | Phathom Pharmaceuticals, Inc. | $12 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-06-05 | Abbott Laboratories | $14 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE Device, Diabetes Care | 2025 | |
| 2025-06-05 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2025 | |
| 2025-06-02 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | BEXSERO Biological, VACCINES | 2025 | |
| 2025-05-30 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-24 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-21 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-20 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-05-19 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-15 | Dexcom, Inc. | $14 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-05-14 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-05-01 | Novo Nordisk Inc | $33 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-24 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-04-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-16 | Astellas Pharma US Inc | $19 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-04-12 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-04-10 | Axsome Therapeutics, Inc. | $27 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-02 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-04-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-01 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-03-27 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-03-27 | Amgen Inc. | $2 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-03-26 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-25 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-21 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-21 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-20 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-19 | Collegium Pharmaceutical, Inc. | $22 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-03-18 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-03-11 | Exact Sciences Corporation | $14 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2025 | |
| 2025-03-05 | Collegium Pharmaceutical, Inc. | $17 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-03-04 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-04 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-24 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-02-22 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-02-21 | Abbott Laboratories | $13 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE Device, Diabetes Care | 2025 | |
| 2025-02-19 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-02-17 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-06 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-06 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-04 | Collegium Pharmaceutical, Inc. | $23 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-02-04 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-02-03 | Phathom Pharmaceuticals, Inc. | $11 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-01-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-01-22 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-22 | Collegium Pharmaceutical, Inc. | $19 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-01-20 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-14 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-01-08 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-01-02 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2024-12-20 | Amgen Inc. | $1 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-12-18 | Axsome Therapeutics, Inc. | $24 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-12-09 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-12-05 | Phathom Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-12-04 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-12-04 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-11-27 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-11-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-20 | Amgen Inc. | $2 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-11-19 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-15 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-11-13 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-11-13 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-11-07 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-06 | Amgen Inc. | $25 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-11-06 | Phathom Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-11-01 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-10-31 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-31 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-10-29 | Exact Sciences Corporation | $17 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-10-24 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-10-23 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-10-23 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-16 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-10-15 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-14 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-10 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-10-08 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-10-08 | Amgen Inc. | $2 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-10-03 | Seqirus USA Inc | $32 | Food and Beverage | In-kind items and services | Fluad Biological, Vaccines | 2024 | |
| 2024-10-02 | Phathom Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-09-24 | IRONSHORE PHARMACEUTICALS INC. | $22 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-09-19 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-09-11 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-09-11 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-09-10 | Axsome Therapeutics, Inc. | $9 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-09-09 | Phathom Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-09-05 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-04 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-03 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-29 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-08-28 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-08-27 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-08-22 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-08-20 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-08-20 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-08-19 | Phathom Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-15 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-07 | IRONSHORE PHARMACEUTICALS INC. | $14 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-08-01 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-08-01 | Novo Nordisk Inc | $4 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-07-30 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-30 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-07-29 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-29 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-07-23 | Astellas Pharma US Inc | $16 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-07-09 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-09 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-08 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-01 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-27 | Abbott Laboratories | $24 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-06-26 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-06-26 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-06-20 | UCB, Inc. | $22 | Food and Beverage | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-06-18 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-14 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-06-13 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-06-13 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-11 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-06-07 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-06-06 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-05-29 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-05-28 | Lilly USA, LLC | $5 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-05-24 | Abbott Laboratories | $17 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-05-23 | Lilly USA, LLC | $1 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-05-22 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-05-22 | Lilly USA, LLC | $5 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-05-21 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-05-16 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-16 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-05-14 | Phathom Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-05-08 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-05-06 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-02 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-05-01 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-04-25 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-04-24 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-04-24 | Lilly USA, LLC | $6 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-04-16 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-10 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-04-10 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-04-09 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-04-09 | Lilly USA, LLC | $4 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-04-08 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-06 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-04-04 | Phathom Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-03-28 | Novo Nordisk Inc | $8 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-03-21 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-03-21 | Lilly USA, LLC | $2 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-03-20 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-20 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-03-19 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-03-19 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2024 | |
| 2024-03-14 | Phathom Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 |
The latest 200 records of 829.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Jackson, MO, county Cape Girardeau County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Jackson, MO | County Cape Girardeau County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 15,659 | 82,735 | 6,191,814 |
| Population, 2020 census P1 | 15,481 | 81,710 | 6,154,913 |
| Median age B01002 | 37.1 | 37.1 | 39.0 |
| Under 18 B01001 | 24.7% | 21.3% | 22.3% |
| 65 and over B01001 | 17.2% | 17.8% | 17.9% |
| Households B11001 | 6,173 | 32,454 | 2,508,227 |
| Foreign born B05002 | 1.7% | 2.4% | 4.5% |
| Median household income B19013 | $77,105 | $68,464 | $70,702 |
| Median family income B19113 | $97,238 | $91,742 | $91,360 |
| Per capita income B19301 | $38,230 | $35,813 | $39,695 |
| Poverty rate B17001 | 8.6% | 13.9% | 12.6% |
| Unemployment rate B23025 | 1.8% | 2.3% | 4.0% |
| Civilian labor force B23025 | 8,339 | 43,387 | 3,120,639 |
| Mean commute (minutes) B08013 | 20.2 | 19.5 | 23.5 |
| Bachelor's degree or higher B15003 | 35.8% | 33.1% | 32.4% |
| Housing units B25001 | 6,427 | 36,086 | 2,825,287 |
| Owner-occupied B25003 | 71.1% | 66.8% | 68.1% |
| Renters B25003 | 28.9% | 33.2% | 31.9% |
| Median home value B25077 | $240,000 | $220,700 | $230,300 |
| Median gross rent B25064 | $900 | $881 | $1,033 |
| White, not Hispanic B03002 | 87.7% | 83.6% | 76.3% |
| Black B03002 | 2.6% | 7.4% | 10.9% |
| Hispanic or Latino B03002 | 4.0% | 2.9% | 5.2% |
| Asian B03002 | 1.3% | 1.6% | 2.1% |
| American Indian and Alaska Native B03002 | 0.7% | 0.2% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Jackson, MO.
Comments